Navigation Links
MDA's Board Chairman Testifies Before US Senate Subcommittee to Advocate for Newborn Screening
Date:9/27/2013

Tucson, AZ (PRWEB) September 27, 2013

Pediatrician and medical geneticist R. Rodney Howell, who chairs MDA's Board of Directors, testified Thursday before the Subcommittee on Children and Families of the U.S. Senate Committee on Health, Education, Labor & Pensions to advocate for passage of the Newborn Screening Saves Lives Reauthorization Act of 2013 (S. 1417).

Howell emphasized that:

  •     conditions that can be detected at birth for which there are emerging therapies should be given priority in the review process for inclusion in the list of recommended newborn screening tests;
  •     priority review will not reduce the scientific rigor of the review process; and
  •     newborn screening reduces the overall cost of illness (sometimes called "burden of disease") for the conditions involved.

"It is important to emphasize that the conditions that are included on the newborn screening panel all result in serious medical complications (e.g., developmental delay) and/or death if not recognized early," Howell told the subcommittee. "All children with these conditions benefit from early diagnosis and treatment."

Three disorders in MDA's program are or may become candidates for addition to the Recommended Uniform Screening Panel (RUSP.) Pompe disease was presented to the Advisory Committee for possible inclusion in the RUSP in January 2013, and the Advisory Committee has recommended that it be added to the RUSP. Spinal muscular atrophy (SMA) was nominated several years ago but not deemed ready for full review by the Advisory Committee; a pilot for SMA newborn screening is under way. In February 2013, scientific information about the feasibility of newborn screening for Duchenne muscular dystrophy (DMD) was presented to the Committee.

A video of the Sept. 26, 2013, Senate subcommittee hearing is available.

To support the Newborn Screening Saves Lives Act, take five minutes to contact your U.S. senator here: mda.org/advocacy/get-involved/legislative-alerts.

About MDA

The Muscular Dystrophy Association is the world’s leading nonprofit health agency dedicated to finding treatments and cures for muscular dystrophy, amyotrophic lateral sclerosis (ALS) and other neuromuscular diseases. It does so by funding worldwide research; by providing comprehensive health care services and support to MDA families nationwide; and by rallying communities to fight back through advocacy, fundraising and local engagement. Visit mda.org and follow us at facebook.com/MDAnational and @MDAnews.

-MDA-

Read the full story at http://www.prweb.com/releases/2013/9/prweb11173040.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Eighth Annual Tradition of Hope Gala to Support MDA's Augie's Quest
2. PreCheck VP of Compliance, Vu T. Do, Elected to NAPBS® Board of Directors
3. PreDiabetes Centers Medical Advisory Board Meets in Austin
4. Board Certified Dermatologist Reveals The Best Time Of The Year For Laser Treatments
5. ThermalDrain™ Synthetic Protection Board Chosen as Finalist for 2013 RISE® Durable Product Awards
6. Excelsius Surgical, LLC Names Fred Moll and Rich Grant to Board of Directors
7. University of Western States Board Elects Executive Committee Members
8. Boyd “Rainmaker” Melson, Professional Athlete and Advocate for Spinal Cord Injury Treatment, Signs on as Advisory Board Member of Store-A-Tooth™ Dental Stem Cell Banking
9. 20 Nursing Students Awarded 2013 APNA Board of Directors Student Scholarships by the American Psychiatric Nurses Association
10. Health Data Intelligence Delivers a Critical Patient Safety and Infection Control Surveillance Tool with the Introduction of the Hospital Complications Dashboard
11. New Online Tote Board to Give Supporters Fundraising Updates During MDA Telethon This Sunday
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 24, 2017 , ... ... of a new report from the Frank Hawkins Kenan Institute of Private ... business leaders, academics and policy makers identified concrete solutions at the “What’s Next, ...
(Date:1/24/2017)... ... January 24, 2017 , ... The NewKILO JRP, a ... (NMIs) and co-funded by the European Union (EU), was completed in May 2015. The ... instead being maintained and used in air, which presents some challenges to establishing traceability ...
(Date:1/24/2017)... ... 2017 , ... A yellow fever outbreak in Brazil has infected over 100 ... primarily spread through contact with infected mosquitos. The outbreak has sparked increased concern about ... , According to multiple health organizations, the best way to prevent yellow fever is ...
(Date:1/24/2017)... ... ... “Who Would Have Dreamed: A Novel of Miracles”: a beautiful and poignant glimpse into ... purpose in her life. “Who Would Have Dreamed: A Novel of Miracles” is the creation ... writing. , Sharon shares that she started her spiritual journey later in life, ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... by patient survivors, today announced formation of its first global advisory board ... initiatives. , Like HCP founders, the global advisory board is composed ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... DIEGO , Jan. 24, 2017 ... in clinical materials management services, is pleased to ... of Operations. Kevin joins the Sherpa team to ... the highest level of service excellence. ... chain and pharmaceutical manufacturing industries. He has extensive ...
(Date:1/24/2017)... BERWYN, Pa. , Jan. 24, 2017 /PRNewswire/ ... Phase 2 biopharmaceutical company developing novel therapies for ... diseases, today announced the appointment of four world-class ... (SAB). These new appointments join QR Pharma,s previous ... strategic leadership and direction to support the development ...
(Date:1/24/2017)... FRANCISCO , January 24, 2017 The global  ... USD 239.8 billion by 2025, based on a new report by Grand ... cancer is projected to drive the market over the forecast period. Advancements ... are also estimated to boost growth.  Continue ... ...
Breaking Medicine Technology: